• Burning Rock’s CanCatch Custom Kit entered China’s NMPA special review procedure for innovative medical devices on Aug. 25, 2026.
• It is the first tumor-informed personalized MRD kit in China to use whole-exome sequencing for baseline profiling.
• Burning Rock cited MEDAL study data showing 0.0036% LOD, 96.6% NPV, with MRD detection leading imaging by 299 days on average.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Burning Rock Biotech Ltd. published the original content used to generate this news brief on August 25, 2026, and is solely responsible for the information contained therein.